Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.21 - $1.75 $2,009 - $2,906
1,661 Added 141.24%
2,837 $4,000
Q4 2023

Feb 14, 2024

SELL
$0.89 - $1.41 $5,011 - $7,939
-5,631 Reduced 82.72%
1,176 $1,000
Q1 2023

May 15, 2023

BUY
$0.88 - $2.19 $433 - $1,079
493 Added 7.81%
6,807 $7,000
Q4 2022

Jun 14, 2023

SELL
$1.27 - $2.26 $626 - $1,114
-493 Reduced 7.24%
6,314 $9.6 Million
Q4 2022

Mar 30, 2023

BUY
$1.27 - $2.26 $205 - $366
162 Added 2.63%
6,314 $9,000
Q4 2022

Feb 15, 2023

BUY
$1.27 - $2.26 $205 - $366
162 Added 2.63%
6,314 $9,000
Q3 2022

Jun 14, 2023

SELL
$1.41 - $2.79 $923 - $1,827
-655 Reduced 9.62%
6,152 $13 Million
Q3 2022

Mar 30, 2023

SELL
$1.41 - $2.79 $13,028 - $25,779
-9,240 Reduced 60.03%
6,152 $13,000
Q3 2022

Nov 14, 2022

BUY
$1.41 - $2.79 $8,674 - $17,164
6,152 New
6,152 $13,000
Q1 2022

May 12, 2022

SELL
$1.91 - $3.98 $29,398 - $61,260
-15,392 Closed
0 $0
Q4 2021

Jun 21, 2023

BUY
$3.53 - $5.5 $30,305 - $47,217
8,585 Added 126.12%
15,392 $57,000
Q4 2021

Mar 30, 2023

SELL
$3.53 - $5.5 $5,955 - $9,278
-1,687 Reduced 9.88%
15,392 $57,000
Q4 2021

Feb 15, 2022

SELL
$3.53 - $5.5 $5,955 - $9,278
-1,687 Reduced 9.88%
15,392 $57,000
Q3 2021

Jun 21, 2023

BUY
$4.99 - $6.55 $51,257 - $67,281
10,272 Added 150.9%
17,079 $85,000
Q3 2021

Mar 30, 2023

SELL
$4.99 - $6.55 $41,007 - $53,827
-8,218 Reduced 32.49%
17,079 $85,000
Q3 2021

Nov 15, 2021

SELL
$4.99 - $6.55 $41,007 - $53,827
-8,218 Reduced 32.49%
17,079 $85,000
Q2 2021

Jun 21, 2023

BUY
$6.24 - $8.22 $115,377 - $151,987
18,490 Added 271.63%
25,297 $164,000
Q2 2021

Mar 30, 2023

BUY
$6.24 - $8.22 $33,558 - $44,207
5,378 Added 27.0%
25,297 $164,000
Q2 2021

Aug 16, 2021

BUY
$6.24 - $8.22 $157,728 - $207,776
25,277 Added 126385.0%
25,297 $165,000
Q1 2021

Jun 26, 2023

BUY
$6.74 - $10.95 $88,374 - $143,576
13,112 Added 192.63%
19,919 $137 Million
Q1 2021

Mar 30, 2023

BUY
$6.74 - $10.95 $7,804 - $12,680
1,158 Added 6.17%
19,919 $137,000
Q1 2021

May 14, 2021

SELL
$6.74 - $10.95 $126,314 - $205,213
-18,741 Reduced 99.89%
20 $137,000
Q4 2020

Jun 22, 2023

BUY
$3.75 - $10.56 $44,827 - $126,234
11,954 Added 175.61%
18,761 $191,000
Q4 2020

Mar 30, 2023

SELL
$3.75 - $10.56 $2,152 - $6,061
-574 Reduced 2.97%
18,761 $191,000
Q4 2020

Feb 16, 2021

SELL
$3.75 - $10.56 $2,152 - $6,061
-574 Reduced 2.97%
18,761 $191,000
Q3 2020

Jun 26, 2023

BUY
$3.5 - $6.2 $43,848 - $77,673
12,528 Added 184.05%
19,335 $67,000
Q3 2020

Mar 30, 2023

SELL
$3.5 - $6.2 $20,062 - $35,538
-5,732 Reduced 22.87%
19,335 $67,000
Q3 2020

Nov 13, 2020

SELL
$3.5 - $6.2 $20,062 - $35,538
-5,732 Reduced 22.87%
19,335 $68,000
Q2 2020

Jun 26, 2023

BUY
$2.16 - $5.46 $39,441 - $99,699
18,260 Added 268.25%
25,067 $125,000
Q2 2020

Mar 30, 2023

SELL
$2.16 - $5.46 $1,587 - $4,013
-735 Reduced 2.85%
25,067 $125,000
Q2 2020

Aug 14, 2020

SELL
$2.16 - $5.46 $1,587 - $4,013
-735 Reduced 2.85%
25,067 $125,000
Q1 2020

Jul 12, 2023

BUY
$1.46 - $7.19 $27,732 - $136,574
18,995 Added 279.05%
25,802 $87,000
Q1 2020

Mar 30, 2023

BUY
$1.46 - $7.19 $28,452 - $140,118
19,488 Added 308.65%
25,802 $87,000
Q1 2020

May 15, 2020

BUY
$1.46 - $7.19 $37,670 - $185,516
25,802 New
25,802 $88,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $354M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.